← Back to patent-cliff list
S1B-509
Tier C — Watch / tradeS1B-509
S1 Biopharma Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Neurotransmitter
Indications (approved)：Obesity
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of S1B-509?
Approved indications include: Obesity.
When does the S1B-509 patent expire?
No public expiry year is available for S1B-509 yet; this page updates once verified.
How do I get a quote for S1B-509 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30